Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07090161 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension

Name: Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension — clinical trial record (NCT07090161)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 2

SponsorVanda Pharmaceuticals

Started2025-09-15

View on ClinicalTrials.gov ↗

Amendment history

2026-02-25

Study Status, Contacts/Locations v3

Study sitesdetails revised at 7 of 28 sites

2026-01-21

Study Status, Contacts/Locations v2

Study sites16→28

2025-11-24

Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1

Trial statusNot Yet Recruiting→Recruiting

Start dateestimated 2025-07-28→confirmed 2025-09-15

Study sites0→16

2025-07-22

Original filing

Vanda Pharmaceuticals

23 trials monitored

See 3 trials at risk

Hypertension

1,786 trials monitored

See 77 trials at risk

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Iloperidone for the Treatment of Participants with Uncontrolled Hypertension

Trial Details

NCT Number	NCT07090161
Lead Sponsor	Vanda Pharmaceuticals
Conditions	Hypertension, Uncontrolled Hypertension
Enrollment	240 participants
Start Date	2025-09-15
Primary Completion	2026-10 (estimated)
Study Completion	2026-11 (estimated)
Updated on ClinicalTrials.gov	2026-02-27